BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2904358)

  • 21. Inhibition of insulin and glucagon secretion by somatostatin: are there indirect effects?
    Smith PH; Chen M; Woods SC; Ensinck JW; Porte D
    Proc Soc Exp Biol Med; 1978 Apr; 157(4):643-7. PubMed ID: 349571
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas.
    Taborsky GJ; Smith PH; Porte D
    Am J Physiol; 1979 Feb; 236(2):E123-8. PubMed ID: 369388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas.
    Ohneda A; Ohneda M
    Tohoku J Exp Med; 1988 Jun; 155(2):197-204. PubMed ID: 3062845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of somatostatin on pancreatic endocrine--experiment by somatostatin infusion into the pancreaticoduodenal artery in dogs--(author's transl)].
    Nakabayashi H; Yoshimitsu K; Kishitani M; Ueda M; Kawato M
    Nihon Naibunpi Gakkai Zasshi; 1976 Mar; 52(3):218-26. PubMed ID: 786754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating somatostatin. Physiological regulator of pancreatic function?
    Gyr K; Beglinger C; Köhler E; Trautzl U; Keller U; Bloom SR
    J Clin Invest; 1987 Jun; 79(6):1595-600. PubMed ID: 2884233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta----alpha----delta pancreatic islet cellular perfusion in dogs.
    Stagner JI; Samols E; Bonner-Weir S
    Diabetes; 1988 Dec; 37(12):1715-21. PubMed ID: 2903837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues.
    Ludvigsen E; Stridsberg M; Taylor JE; Culler MD; Oberg K; Janson ET; Sandler S
    Regul Pept; 2007 Jan; 138(1):1-9. PubMed ID: 16935361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia.
    Klaff LJ; Taborsky GJ
    Diabetes; 1987 May; 36(5):592-6. PubMed ID: 2883057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential neural regulation of circulating somatostatin-14 and somatostatin-28 in conscious dogs.
    Greenberg GR
    Am J Physiol; 1993 May; 264(5 Pt 1):G902-9. PubMed ID: 8098911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas.
    Qader SS; Håkanson R; Rehfeld JF; Lundquist I; Salehi A
    Regul Pept; 2008 Feb; 146(1-3):230-7. PubMed ID: 17942170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatostatin analogs inhibit somatostatin release.
    Ipp E; Rivier J; Dobbs RE; Brown M; Vale W; Unger RH
    Endocrinology; 1979 May; 104(5):1270-3. PubMed ID: 436775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Action of [3,14-L-selenocysteine, 8-D-tryptophan]-somatostatin on insulin and glucagon secretion of the isolated perfused pancrease of the Wistar rat].
    Bierwolf B; Hartrodt B; Neubert R; Jakubke HD; Blech W
    Biomed Biochim Acta; 1986; 45(5):611-8. PubMed ID: 2875714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
    Lickley HL; Kemmer FW; Doi K; Vranic M
    Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of somatostatin-28 on dynamics of insulin secretion in perfused rat pancreas.
    Ensinck JW; Laschansky EC; Vogel RE; D'Alessio DA
    Diabetes; 1991 Sep; 40(9):1163-9. PubMed ID: 1682197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs.
    Gordin A; Meyers C; Arimura A; Coy DH; Schally AV
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):833-41. PubMed ID: 335762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-response effect of somatostatin-14 on human basal pancreatic hormones.
    Annibale B; Delle Fave G; Barbetti F; de Magistris L; Puoti M; Giordano E; Leonetti F; Tamburrano G
    Pancreas; 1987; 2(5):551-6. PubMed ID: 2890157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin and glucagon secretion in rats: effects of calcitonin gene-related peptide.
    Pettersson M; Ahrén B
    Regul Pept; 1988 Oct; 23(1):37-50. PubMed ID: 2907171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of somatostatin inhibition of insulin and glucagon secretion.
    Bhathena SJ; Perrino PV; Voyles NR; Smith SS; Wilkins SD; Coy DH; Schally AV; Recant L
    Diabetes; 1976 Nov; 25(11):1031-40. PubMed ID: 992224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nervous control of rat somatostatin, glucagon and insulin secretions.
    Marre M; Bobbioni E; Sheppard M; Kronheim S; Miller J; Assan R
    Diabete Metab; 1982 Sep; 8(3):179-86. PubMed ID: 6128263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients.
    Colturi TJ; Unger RH; Feldman M
    J Clin Invest; 1984 Aug; 74(2):417-23. PubMed ID: 6146638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.